Eunjoon Kim
Neuroscientist who directs the IBS Center for Synaptic Brain Dysfunctions and studies synaptic scaffold proteins linked to autism; he contributed to work linking neuronal ERBB4 and mTOR signalling to Alzheimer's pathology
Professor, KAIST Department of Biological Sciences · Director, IBS Center for Synaptic Brain Dysfunctions · over 200 papers · Asan Award in Medicine (2018), POSCO TJ Park Prize (2013)
Center for Synaptic Brain Dysfunctions, Institute for Basic Science & Department of Biological Sciences, KAIST (Daejeon, South Korea) ↗ ORCID0000-0001-5518-6584 ↗
Portrait: IBS Center for Synaptic Brain Dysfunctions
Eunjoon Kim built his career mapping the molecular architecture of the synapse — in particular the SHANK family of postsynaptic scaffold proteins, whose mutations are among the best-established genetic causes of autism spectrum disorder. He now directs the IBS Center for Synaptic Brain Dysfunctions at KAIST, with over 200 papers published.
In this 2026 Nature paper from Won-Suk Chung's group (also at KAIST/IBS), Kim is a co-author on work showing that aberrant ERBB4 expression in excitatory neurons drives synapse loss, amyloid deposition, and cognitive decline via mTOR signaling — connecting his long-standing expertise in synaptic biology to the molecular front lines of neurodegeneration.
Milestones in the Atlas
| Year | Evidence | Study |
|---|---|---|
| 2026 | A | Aberrant excitatory neuronal ERBB4 promotes Alzheimer's disease pathology LEE2026 Co-author (director, IBS Center for Synaptic Brain Dysfunctions; KAIST) on a 2026 Nature study showing aberrant ERBB4 expression in excitatory neurons drives Alzheimer's-like synapse loss and pathology via mTOR signaling. |
Co-authors in the Atlas
People with a profile here who share at least one study with Eunjoon Kim.
- Seongbin Kim Contributed to a 2026 study showing that abnormal ERBB4 in excitatory neurons drives Alzheimer's pathology through mTOR signalling